Neuroinflammation and demyelination in multiple sclerosis after allogeneic hematopoietic stem cell transplantation

Archives of Neurology

Volumn 67, Issue 6, 2010, Pages 716-722

  Lu, Jian Qiang ^a,e   Joseph, Jeffrey T ^a   Nash, Richard A ^b   Storek, Jan ^a   Stevens, Anne M ^c   Metz, Luanne M ^a   Clark, Arthur W ^a   Johnson, Edward S ^d   Yong, V Wee ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

^e UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOPSY; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DEMYELINATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MACROPHAGE; MICROGLIA; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; PRIORITY JOURNAL; WHITE MATTER;

ADULT; AMYLOID BETA-PROTEIN PRECURSOR; ANTIGENS, CD; CASE-CONTROL STUDIES; DEMYELINATING DISEASES; ENCEPHALITIS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POSTMORTEM CHANGES; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTE SUBSETS; TRANSPLANTATION, HOMOLOGOUS;

EID: 77953635372     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2010.117     Document Type: Article

References (40)

1. Mancardi G, Saccardi R. Autologous haematopoietic stem-cell transplantation in multiple sclerosis. Lancet Neurol. 2008;7(7):626-636.
2. Weiner HL. A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis. J Neurol. 2008;255(suppl 1):3-11.
3. Frohman EM, Racke MK, Raine CS. Multiple sclerosis: the plaque and its pathogenesis. N Engl J Med. 2006;354(9):942-955.
4. Burt RK, Cohen B, Rose J, et al. Hematopoietic stem cell transplantation for multiple sclerosis. Arch Neurol. 2005;62(6):860-864.
5. Sykes M, Nikolic B. Treatment of severe autoimmune disease by stem-cell transplantation. Nature. 2005;435(7042):620-627. (Pubitemid 40825502)
6. Van Wijmeersch B, Sprangers B, Dubois B, Waer M, Billiau AD. Autologous and allogeneic hematopoietic stem cell transplantation for multiple sclerosis: perspective on mechanisms of action. J Neuroimmunol. 2008;197(2):89-98.
7. Metz I, Lucchinetti CF, Openshaw H, et al. Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis. Brain. 2007;130(pt 5):1254-1262. (Pubitemid 47355940)
8. Griffith LM, Pavletic SZ, Tyndall A, et al; Workshop participants. Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease. Biol Blood Marrow Transplant. 2005;11(11):862-870.
9. Padovan CS, Gerbitz A, Sostak P, et al. Cerebral involvement in graft-versus-host disease after murine bone marrow transplantation. Neurology. 2001;56(8):1106-1108. (Pubitemid 32336324)
10. Siegal D, Keller A, Xu W, et al. Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance. Biol Blood Marrow Transplant. 2007;13(11):1369-1379.
11. McAllister LD, Beatty PG, Rose J. Allogeneic bone marrow transplant for chronic myelogenous leukemia in a patient with multiple sclerosis. Bone Marrow Transplant. 1997;19(4):395-397. (Pubitemid 27096075)
12. Mandalfino P, Rice G, Smith A, Klein JL, Rystedt L, Ebers GC. Bone marrow transplantation in multiple sclerosis. J Neurol. 2000;247(9):691-695.
13. La Nasa G, Littera R, Cocco E, Battistini L, Marrosu MG, Contu L. Allogeneic hematopoietic stem cell transplantation in a patient affected by large granular lymphocyte leukemia and multiple sclerosis. Ann Hematol. 2004;83(6):403-405. (Pubitemid 38684458)
14. Jeffery DR. Failure of allogeneic bone marrow transplantation to arrest disease activity in multiple sclerosis. Mult Scler. 2007;13(8):1071-1075.
15. Lu JQ, Storek J, Metz L, et al. Continued disease activity in a patient with multiple sclerosis after allogeneic hematopoietic cell transplantation. Arch Neurol. 2009;66(1):116-120.
16. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis. Ann Neurol. 2001;50(1):121-127.
17. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med. 1998;338(5):278-285. (Pubitemid 28065253)
18. van der Valk P, De Groot CJ. Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS. Neuropathol Appl Neurobiol. 2000;26(1):2-10.
19. Brück W, Porada P, Poser S, et al. Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann Neurol. 1995;38(5):788-796.
20. Rzeski W, Pruskil S, Macke A, et al. Anticancer agents are potent neurotoxins in vitro and in vivo. Ann Neurol. 2004;56(3):351-360.
21. Erbetta A, Salmaggi A, Sghirlanzoni A, et al. Clinical and radiological features of brain neurotoxicity caused by antitumor and immunosuppressant treatments. Neurol Sci. 2008;29(3):131-137. (Pubitemid 352003647)
22. Motl S, Zhuang Y, Waters CM, Stewart CF. Pharmacokinetic considerations in the treatment of CNS tumours. Clin Pharmacokinet. 2006;45(9):871-903. (Pubitemid 44313694)
23. Coisne C, Lyck R, Engelhardt B. Therapeutic targeting of leukocyte trafficking across the blood-brain barrier. Inflamm Allergy Drug Targets. 2007;6(4):210-222. (Pubitemid 351144584)
24. Ma M, Barnes G, Pulliam J, Jezek D, Baumann RJ, Berger JR. CNS angiitis in graft vs host disease. Neurology. 2002;59(12):1994-1997. (Pubitemid 36076582)
25. Mondria T, Lamers CH, te Boekhorst PA, Gratama JW, Hintzen RQ. Bone-marrow transplantation fails to halt intrathecal lymphocyte activation in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2008;79(9):1013-1015.
26. Welniak LA, Blazar BR, Murphy WJ. Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu Rev Immunol. 2007;25:139-170. (Pubitemid 46697905)
27. Duran-Struuck R, Reddy P. Biological advances in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation. 2008;85(3):303-308.
28. Openshaw H, Stuve O, Antel JP, et al. Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor. Neurology. 2000;54(11):2147-2150.
29. Nash RA, Stuve O, Bowen JD, et al. Autologous HSCT for advanced MS. Brain. 2008;131(pt 2):e89. doi:10.1093/brain/awm180.
30. Metz I, Lucchinetti CF, Openshaw H, et al. Autologous hematopoietic stem cell transplantation. Brain. 2008;131(pt 2):e90. doi:10.1093/brain/awm181.
31. Andersen O, Lygner PE, Bergstrom T, Andersson M, Vahlne A. Viral infections trigger multiple sclerosis relapses. J Neurol. 1993;240(7):417-422.
32. Monteyne P, Bureau JF, Brahic M. Viruses and multiple sclerosis. Curr Opin Neurol. 1998;11(4):287-291.
33. Steiner I, Nisipianu P, Wirguin I. Infection and the etiology and pathogenesis of multiple sclerosis. Curr Neurol Neurosci Rep. 2001;1(3):271-276.
34. Mackay CR, Marston WL, Dudler L. Naive and memory T cells show distinct pathways of lymphocyte recirculation. J Exp Med. 1990;171(3):801-817.
35. von Boehmer H, Hafen K. The life span of naive alpha/beta T cells in secondary lymphoid organs. J Exp Med. 1993;177(4):891-896.
36. Tough DF, Sprent J. Life span of naive and memory T cells. Stem Cells. 1995;13(3):242-249.
37. Oksenberg JR, Baranzini SE, Sawcer S, Hauser SL. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat Rev Genet. 2008;9(7):516-526.
38. Ramagopalan SV, Knight JC, Ebers GC. Multiple sclerosis and the major histocompatibility complex. Curr Opin Neurol. 2009;22(3):219-225.
39. Graca L, Cobbold SP, Waldmann H. Identification of regulatory T cells in tolerated allografts. J Exp Med. 2002;195(12):1641-1646.
40. + regulatory T cells increase de novo in kidney transplant patients after immunodepletion with campath-1H. Am J Transplant. 2008;8(4):793-802.